From Fierce Biotech
-
Pfizer reports death of young boy with DMD who participated in gene therapy trial
A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7
-
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
Amgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. | Amgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide.
-
Novartis further entrenches into radiopharma with $1B Mariana buy
With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown with Mariana Oncology in a $1 billion upfront acquisition. | With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown with Mariana Oncology in a $1 billion upfront acquisition.